Daratumumab in Combination With ATRA (Q66404694)
Jump to navigation
Jump to search
clinical trial
Language | Label | Description | Also known as |
---|---|---|---|
English | Daratumumab in Combination With ATRA |
clinical trial |
Statements
DARA/ATRA (English)
0 references
A Phase 1 and Phase 2 Study of Daratumumab in Combination With All-trans Retinoic Acid in Relapsed/Refractory Multiple Myeloma (English)
0 references
6 July 2016
0 references
1 May 2019
0 references
60
0 references
18 year
0 references